← Back to Search

Brain Health Assessment for Dementia (eRADAR Trial)

N/A

Waitlist Available

Led By Deborah Barnes, PhD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months after invitation mailed

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to make dementia detection easier and more affordable for primary care, to help those at risk get the care they need.

Who is the study for?

This trial is for individuals who have not been diagnosed with dementia and are not on any dementia medications. Participants must be active patients at a participating clinic and have enough data available to calculate what's called an eRADAR score. People currently in hospice care cannot join.

What is being tested?

The study is testing a new, cost-effective way to spot dementia early in primary care settings by using something called the Brain Health Assessment, which likely involves tests or questionnaires designed to evaluate memory and thinking skills.

What are the potential side effects?

Since this trial involves assessments rather than medication or invasive procedures, side effects are minimal but may include discomfort or stress during cognitive evaluations.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months after invitation mailed

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months after invitation mailed

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after invitation mailed for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

New dementia diagnosis

Secondary study objectives

New dementia diagnosis (secondary definitions)

New diagnosis of mild cognitive impairment

Number of dementia-related laboratory tests performed

+10 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Brain Health InterventionExperimental Treatment1 Intervention

Calculate eRADAR scores using EHR data to identify eligible individuals Invite eligible individuals for brain health assessment visit Enter results of brain health assessment visit into EHR Provide summary of results and recommended next steps to the Primary Care Physician and participant

Group II: Usual CareActive Control1 Intervention

Usual care Individuals who meet eligibility criteria will receive usual care.

Do I qualify?Apply below to find out